CLINICAL_TRIALS ClinicalTrials.gov record update

TRIAL EVALUATING EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19, NESTED IN THE CORIMUNO-19 COHORT

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04822818
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:51.443851+00:00
Published At: 2022-12-28T00:00:00+00:00
Record Updated At: 2022-12-28
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Corona Virus Infection", "SARS (Severe Acute Respiratory Syndrome)", "Virus Diseases", "Coronaviridae Infections", "Nidovirales Infections", "RNA Virus Infections", "Respiratory Tract Infections", "Respiratory Tract Diseases"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-12-28"
protocolSection.identificationModule.nctId: "NCT04822818"
protocolSection.identificationModule.officialTitle: "TRIAL EVALUATING EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV\u00ae) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19, NESTED IN THE CORIMUNO-19 COHORT"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.